Echo Therapeutics, Inc. Notes Payable, Fair Value Disclosure
Echo Therapeutics, Inc. had Notes Payable, Fair Value Disclosure of $3.00 million as of 2012-12-31, per its 10-K filed 2013-03-18.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures
us-gaap:NotesPayableFairValueDisclosure · last filed 2013-03-18
- 2012-12-31: Notes Payable, Fair Value Disclosure $3.00M.
| Period end | Notes Payable, Fair Value Disclosure |
|---|---|
| 2012-12-31 | $3.00M 10-K · filed 2013-03-18 |